<div>Researchers in the United States have demonstrated the effectiveness of three antibody agents at neutralizing recently emerged variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) &ndash; the agent responsible for the coronavirus disease 2019 (COVID-19) pandemic.</div>